4.4 Review

The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review

Journal

BMC NEPHROLOGY
Volume 20, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s12882-019-1384-0

Keywords

Sport supplements; Growth hormone; Anabolic-androgenic steroids; Kidney; Adverse effects

Ask authors/readers for more resources

Background: Anabolic-androgenic steroids and growth hormone are among the most commonly used supplements by sportsmen and sportswomen. The aim of this systematic review is to collect and report available data about renal safety of anabolic-androgenic steroids and growth hormone (GH). Methods: The search strategy was in accordance with the PRISMA guideline. Seven databases such as Scopus, Medline, Embase, and ISI Web of Knowledge were searched using keywords, such as growth hormone, anabolic-androgenic steroids, and kidney injury. Articles published from 1950 to December 2017 were considered. Randomized clinical trials, prospective or retrospective human studies, case series as well as case reports, and experimental (in vivo) studies were included. Twenty one clinical and experimental articles were selected (12 for anabolic-androgenic steroids and 9 for GH). Results: Anabolic-androgenic steroids can affect the kidney in different aspects. They can induce or aggravate acute kidney injury, chronic kidney disease, and glomerular toxicity. These adverse effects are mediated through pathways such as stimulating renin-angiotensin-aldosterone system, enhancing the production of endothelin, producing reactive oxygen species, over-expression of pro-fibrotic and pro-apoptotic mediators (e.g., TGF-beta 1), as well as inflammatory cytokines (e.g., TNF-alpha, IL-1b, and IL-6). Although GH may affect the kidney in different aspects, such as size, glomerular filtration rate, and tubule functions, either directly or indirectly, there is no conclusive clinical evidence about its detrimental effects on the kidney in athletes and body builders. Conclusion Evidence regarding effects of anabolic-androgenic steroids exists; However, GH's exact effect on the kidney at doses used by athletes and body builders has not yet been clarified. Cohort clinical studies with long-term follow-up are warranted in this regard.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Pharmacology & Pharmacy

Protective effects of pharmacological agents against aminoglycoside-induced nephrotoxicity: A systematic review

Motahareh Mahi-Birjand, Sajad Yaghoubi, Meghdad Abdollahpour-Alitappeh, Zahra Keshtkaran, Nader Bagheri, Aliyar Pirouzi, Mehrdad Khatami, Koushan Sineh Sepehr, Payam Peymani, Man Karimzadeh

EXPERT OPINION ON DRUG SAFETY (2020)

Article Transplantation

The Pattern of Cyclosporine Nephrotoxicity and Urinary Kidney Injury Molecule 1 in Allogenic Hematopoietic Stem Cell Transplant Patients

Iman Karimzadeh, Mahtab Jafari, Dorna Davani-Davari, Mani Ramzi

Summary: The study revealed that cyclosporine nephrotoxicity is a common adverse effect in hematopoietic stem cell transplant patients, mostly occurring within the first two weeks of treatment. Urine KIM-1 kidney injury molecule measurement did not show overall superiority and did not improve accuracy over serum or urine creatinine measurements in predicting or detecting cyclosporine nephrotoxicity.

EXPERIMENTAL AND CLINICAL TRANSPLANTATION (2021)

Article Infectious Diseases

Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial

Amirreza Roostaei Firozabad, Zohreh Akhoundi Meybodi, Seyed Ruhollah Mousavinasab, Adeleh Sahebnasagh, Mohsen Gholinataj Jelodar, Iman Karimzadeh, Solomon Habtemariam, Fatemeh Saghafi

Summary: This study suggests that Levamisole may improve most clinical statuses of patients with COVID-19, particularly in terms of cough and dyspnea. However, the clinical importance of this finding remains uncertain.

BMC INFECTIOUS DISEASES (2021)

Article Urology & Nephrology

A randomized double-blinded placebo-controlled clinical trial on protective effects of pentoxifylline on gentamicin nephrotoxicity in infectious patients

Seyed Ruhollah Mousavinasab, Zohreh Akhoundi-Meybodi, Laleh Mahmoudi, Iman Karimzadeh

Summary: This clinical trial demonstrated that oral administration of 400 mg pentoxifylline three times a day in combination with gentamicin was effective in preventing nephrotoxicity and well tolerated in patients with different infectious diseases.

CLINICAL AND EXPERIMENTAL NEPHROLOGY (2021)

Article Gastroenterology & Hepatology

Cost-utility Analysis of Second-generation Direct-acting Antivirals for Hepatitis C

Zahra Goudarzi, Abdollah Poursamad, Iman Karimzadeh, Nahid Jallaly, Khosro Keshavarz, Seyed Moayed Alavian

Summary: The study evaluated the cost-effectiveness of three medication regimens for HCV genotype 1 patients in Iran. Results indicated that VEL/SOF regimen was the most cost-effective strategy, followed by LDV/SOF and DCV/SOF.

HEPATITIS MONTHLY (2021)

Article Immunology

Outcomes of Implementing an Infectious Diseases Approval of Selected Antimicrobials as an Antimicrobial Stewardship Initiative in a Referral Hospital in Iran

Iman Karimzadeh, Samira Hossaini Alhashemi, Seyedeh Shima Ghetmiri, Afsaneh Vazin

Summary: This study investigated the clinical and economic benefits of an antimicrobial stewardship program on 5 costly antimicrobial drugs in a large referral teaching hospital. The study found that the active contribution of infectious diseases specialists in the program significantly reduced the total cost and defined daily dose of high-cost antimicrobial medications, while improving clinical outcomes.

INFECTIOUS DISEASES IN CLINICAL PRACTICE (2022)

Article Critical Care Medicine

The clinical and paraclinical effectiveness of four-hour infusion vs. half-hour infusion of high-dose ampicillin-sulbactam in treatment of critically ill patients with sepsis or septic shock: An assessor-blinded randomized clinical trial

Mahtabalsadat Mirjalili, Farid Zand, Iman Karimzadeh, Mansoor Masjedi, Golnar Sabetian, Ehsan Mirzaei, Afsaneh Vazin

Summary: This study compared the efficacy of extended infusion and intermittent infusion of ampicillin/sulbactam in the treatment of sepsis and septic shock patients in the ICU. The results showed that the extended group had significantly higher clinical cure rates, while there were no significant differences in ICU and hospital length of stay. Additionally, the ICU and hospital mortality rates were significantly lower in the extended infusion group.

JOURNAL OF CRITICAL CARE (2023)

Review Health Care Sciences & Services

Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Economic Evaluations

Zahra Goudarzi, Mohsen Ghafari Darab, Afsaneh Vazin, Amirreza Hayatbakhsh, Iman Karimzadeh, Mojtaba Jafari, Khosro Keshavarz, Afshin Borhani-Haghighi

Summary: This study reviewed and systematically analyzed the cost-utility studies results of warfarin compared with other NOAC drugs in atrial fibrillation patients. The findings showed that NOAC drugs have acceptable cost-effectiveness in developed and developing countries, with apixaban having the lowest incremental cost-effectiveness ratio and the highest cost-effectiveness.

VALUE IN HEALTH REGIONAL ISSUES (2023)

Review Pharmacology & Pharmacy

Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications

Parisa Ghasemiyeh, Negar Mortazavi, Iman Karimzadeh, Afsaneh Vazin, Laleh Mahmoudi, Ebrahim Moghimi-Sarani, Ashkan MohammadSadeghi, Mina Shahisavandi, Ali Kheradmand, Soliman Mohammadi-Samani

Summary: Management of COVID-19 in patients with predisposing psychiatric disorders is challenging due to potential drug-drug interactions and exacerbation of their conditions. COVID-19 itself may also lead to unexpected psychiatric and neuropsychiatric complications in these patients. The most common type of major drug-drug interactions identified in this study is pharmacokinetics, with hydroxychloroquine/chloroquine and lopinavir/ritonavir being the most implicated anti-COVID-19 agents.

IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (2021)

Article Medicine, Research & Experimental

Pharmacotherapy for reducing saliva and droplet production in airborne procedures may help to decrease the COVID-19 transmission: A hypothesis

Ashkan MohammadSadeghi, Iman Karimzadeh, Kamran Bagheri Lankarani, Morteza Banakar

MEDICAL HYPOTHESES (2020)

Article Chemistry, Medicinal

A simple and validated HPLC method for vancomycin assay in plasma samples: the necessity of TDM center development in Southern Iran

Parisa Ghasemiyeh, Afsaneh Vazin, Farid Zand, Amir Azadi, Iman Karimzadeh, Soliman Mohammadi-Samani

RESEARCH IN PHARMACEUTICAL SCIENCES (2020)

Article Chemistry, Medicinal

Comparison of intravenous sodium bicarbonate and sodium chloride combination versus intravenous sodium chloride hydration alone in reducing amphotericin B nephrotoxicity: a randomized clinical trial

Iman Karimzadeh, Asma Sepehr-Sobhani, Mohammad Khoshnoud, Mohammad Sagheb, Reza Vejdani, Atefeh Jalali, Motahareh Mahi-Birjand

RESEARCH IN PHARMACEUTICAL SCIENCES (2020)

Article Transplantation

Drug-Drug Interactions among Kidney Transplant Recipients in The Outpatient Setting

O. Moradi, I Karimzadeh, D. Davani-Davari, M. Shafiekhani, M. M. Sagheb, G. A. Raees-Jalali

INTERNATIONAL JOURNAL OF ORGAN TRANSPLANTATION MEDICINE (2020)

Article Pharmacology & Pharmacy

Protective Effects of Silymarin on Gentamicin-Induced Nephrotoxicity in Infectious Patients: A Randomized Double Blinded Placebo-Controlled Clinical Trial

Motahareh Mahi-Birjand, Imam Karimzadeh, Asghar Zarban, Meghdad Abdollahpour-Alitappeh, Seyed Alireza Saadatjoo, Masood Ziaee

PHARMACEUTICAL SCIENCES (2020)

Article Urology & Nephrology

Evaluation of colistin nephrotoxicity and urinary level of kidney injury molecule-1 in hospitalized adult ICU patients

Afsaneh Vazin, Maryam Malek, Iman Karimzadeh

JOURNAL OF RENAL INJURY PREVENTION (2020)

No Data Available